Clik here to view.
武田宣布将在即将召开的股东大会上公布董事会候选人
日本大阪 (美国商业资讯)–武田(Takeda)(TSE:4502/NYSE:TAK)宣布，公司董事会今天决定，董事会将在2023年6月28日举行的第147次普通股东大会上提议一名新的独立外部董事候选人。如果得到股东的批准，新候选人Miki Tsusaka将于6月28日加入董事会。此外，日本总务部代表董事Masato...
View ArticleClik here to view.
REGiMMUNE Limited Licenses the Rights to Develop and Commercialize RGI-2001...
TAIPEI, Taiwan REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu...
View ArticleClik here to view.
Wyss Center（ジュネーブ）、新CEOにアーウィン・ベッティンガー氏を任命
ジュネーブ （ビジネスワイヤ） — 非営利の研究所であるWyss Center for Bio and Neuroengineeringの理事会は、医学博士であるアーウィン・ベッティンガー氏を新たな最高執行責任者（CEO）に任命したことを発表しました。...
View ArticleClik here to view.
Wyss Center（日内瓦）任命Erwin Böttinger为新一任首席执行官
日内瓦 (美国商业资讯)–非营利研究中心Wyss Center for Bio and Neuroengineering执行董事会很高兴地宣布，任命医学博士Erwin Böttinger教授为新一任首席执行官(CEO)。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20230331005255/zh-CN/...
View ArticleClik here to view.
InnoCare Announces First Subject Dosed in Clinical Trial of Novel Targeted...
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been...
View ArticleClik here to view.
PHC株式会社：非黒色腫皮膚がん分野における検査機器の共同開発に向けた実現性検討をNovaScan, Inc.と開始
東京 （ビジネスワイヤ） — PHC株式会社（本社：東京都港区、代表取締役社長：中村 伸朗、以下「PHC」）と、NovaScan, Inc.（本社：イリノイ州・シカゴ、CEO：Craig Davis、以下「NovaScan」）は、このたび、病理診断領域の非黒色腫皮膚がん分野における生体外検査機器「MarginScanTM」の共同開発に向けて、実現性検討を開始しましたので、お知らせします。...
View ArticleClik here to view.
PHC Corporation and NovaScan, Inc. Launch Collaboration to Explore the...
TOKYO PHC Corporation (headquarters: Minato-ku, Tokyo, President: Nobuaki Nakamura, hereafter PHC) and NovaScan, Inc. (headquarters: Chicago, Illinois, CEO: Craig Davis, hereafter NovaScan) announce...
View ArticleClik here to view.
ZAP Surgical Receives Regulatory Approval in India for Its First ZAP-X...
SAN CARLOS, Calif. ZAP Surgical Systems, Inc. today announced that the company received regulatory approval in India for its first ZAP-X® Gyroscopic Radiosurgery® platform in the form of a No...
View ArticleClik here to view.
Evopoint Announces Clinical Trial Collaboration Agreement with MSD for the...
SUZHOU, China Evopoint Biosciences Co., Ltd.(“Evopoint”), a biopharmaceutical company focused on discovering and developing innovative and transformative medicines, announced today a collaboration...
View ArticleClik here to view.
OrganaBio Delivers RUO ＆ GMP LeukoPAC™ Collections to Singapore
MIAMI The monoclonal antibodies (mAbs) daratumumab, and elotuzumab have been approved by the U.S. Food and Drug Administration for treating multiple myeloma (MM) in 2015. Although clinical responses...
View ArticleClik here to view.
Syncell Showcases Pioneering Microscopy-Guided Subcellular Protein Scooping...
TAIPEI, Taiwan & LOS ALTOS, Calif. Syncell, a biotech company pioneering in platforms for hypothesis-free spatial proteomics, will be exhibiting and presenting a poster at the AACR Annual...
View ArticleClik here to view.
CANbridge Pharmaceuticals Spinal Muscular Atrophy Gene Therapy Abstract...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (1228.HK), a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
Biomunex Pharmaceuticals, a French Company Specialized in Immunotherapy,...
PARIS & CAMBRIDGE, Mass. Biomunex Pharmaceuticals, a French biopharmaceutical company focused on the development of immunotherapies based on the discovery and development of bi- and...
View ArticleClik here to view.
Turnstone Biologics to Present Preclinical Data for Selected TIL Therapy at...
SAN DIEGO Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat solid tumors, today announced that two abstracts have been accepted for...
View ArticleClik here to view.
BeiGene Expands Presence in Latin America With Opening of Brazil Office
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the first major step in the company’s...
View ArticleClik here to view.
Alentis Therapeutics 完成 1.05 亿美元 C 轮融资，助力推进以 Claudin-1 为标靶的转化医学进程
瑞士巴塞尔 (美国商业资讯)–Alentis Therapeutics (“Alentis”)，是一家临床阶段生物制药公司，专注于研发以 Claudin-1 (CLDN1) 为标靶的突破性靶向疗法，用于治疗器官纤维化和 CLDN1 阳性肿瘤。今日，Alentis 宣布完成 1.05 亿美元 C 轮融资。本轮融资由 Jeito Capital、Novo Holdings A/S 和 RA...
View ArticleClik here to view.
Bio-Thera Solutions Announces BAT1006 Poster Presentations at the 2023 AACR...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced the company will present one poster concerning Phase 1 clinical results for...
View ArticleClik here to view.
MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & SAN MATEO, Calif. & STAMFORD, Conn. MapKure, LLC, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks...
View ArticleClik here to view.
BeiGene and SpringWorks Present Clinical Data on Lifirafenib, in Combination...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & STAMFORD, Conn. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today...
View ArticleClik here to view.
Data of InnoCare’s Robust Oncology Pipelines Presented at the 2023 AACR...
BEIJING Data of InnoCare’s (HKEX: 09969; SSE: 688428) robust oncology pipelines were presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting. Oral Presentation: ICP-490...
View Article